Artificial and bioartificial liver support

Organogenesis

Volumn 3, Issue 1, 2007, Pages

  Pless, Gesine ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Artificial liver support; Bioartificial liver support; Bioreactor; Hepatocytes; Liver failure

Indexed keywords

ARTIFICIAL LIVER; BIOARTIFICIAL LIVER; CLINICAL STUDY; CONTROL GROUP; DETOXIFICATION; FILTRATION; FOLLOW UP; HEMODIALYSIS; HUMAN; LIVER CELL; LIVER FAILURE; LIVER TRANSPLANTATION; PARTIAL HEPATECTOMY; PATIENT ASSESSMENT; POSTOPERATIVE CARE; REVIEW;

EID: 38349032702     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.3.1.3635     Document Type: Review

References (49)

1. Holt AW. Acute liver failure. Crit Care Resusc 1999; 1:25-38.
2. Gimson AE, Braude S, Mellon PJ, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982; 2:681-3.
3. Gazzard BG, Weston MJ, Murray-Lyon IM, Flax H, Record CO, Williams R, Portmann B, Langley PG, Dunlop EH, Mellon PJ, Ward MB. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974; 1:1301-7.
4. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94:1186-92.
5. Freeman JG, Matthewson K, Record CO. Plasmapheresis in acute liver failure. Int J Artif Organs 1986; 9:433-8.
6. Clemmesen JO, Larsen FS, Ejlersen E, Schiodt FV, Ott P, Hansen BA. Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure. Eur J Gastroenterol Hepatol 1997; 9:55-60.
7. Li LJ, Zhang YM, Liu XL, Du WB, Huang JR, Yang Q, Xu XW, Chen YM. Artificial liver support system in China: A review over the last 30 years. Ther Apher Dial 2006; 10:160-7.
8. Campli CD, Gaspari R, Mignani V, Stifano G, Santoliquido A, Verme LZ, Proietti R, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A. Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure. Artif Organs 2003; 27:565-9.
9. Doria C, Mandala L, Scott VL, Gruttadauria S, Marino IR. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: A single-center experience. Dig Dis Sci 2006; 51: 47-53.
10. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: A summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002; 26:103-10.
11. Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: A meta-analysis. Liver Transpl 2004; 10:1099-106.
12. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Lohr JM, Liebe S, Emmrich J, Korten G, Schmidt R. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6:277-86.
13. Chiu A, Fan ST. MARS in the treatment of liver failure: Controversies and evidence. Int J Artif Organs 2006; 29:660-7.
14. Chawla LS, Georgescu F, Abell B, Seneff MG, Kimmel PL. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis 2005; 45:e51-6.
15. Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, Hwang YJ, Pascher A, Gerlach JC, Neuhaus P. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004; 39:1408-14.
16. Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y. Detoxifying capacity and kinetics of prometheus-a new extracorporeal system for the treatment of liver failure. Blood Purif 2005; 23:349-58.
17. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D. Prometheus-a new extracorporeal system for the treatment of liver failure. J Hepatol 2003; 39:984-90.
18. Rifai K, Manns MP. Review article: Clinical experience with Prometheus. Ther Apher Dial 2006; 10:132-7.
19. Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D. Removal selectivity of Prometheus: A new extracorporeal liver support device. World J Gastroenterol 2006; 12:940-4.
20. Rifai K, Ernst T, Kretschmer U, Hafer C, Haller H, Manns MP, Fliser D. The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005; 23:298-302.
21. Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y. Prometheus versus molecular adsorbents recirculating system: Comparison of efficiency in two different liver detoxification devices. Artif Organs 2006; 30:276-84.
22. Rozga J, Umehara Y, Trofimenko A, Sadahiro T, Demetriou AA. A novel plasma filtration therapy for hepatic failure: Preclinical studies. Ther Apher Dial 2006; 10:138-44.
23. Morsiani E, Brogli M, Galavotti D, Pazzi P, Puviani AC, Azzena GF. Biologic liver support: Optimal cell source and mass. Int J Artif Organs 2002; 25:985-93.
24. Stange J, Mitzner S, Strauss M, Fischer U, Lindemann S, Peters E, Holtz M, Drewelow B, Schmidt R. Primary or established liver cells for a hybrid liver? Comparison of metabolic features. Asaio J 1995; 41:M310-5.
25. Sauer IM, Gerlach JC. Modular extracorporeal liver support. Artif Organs 2002; 26:703-6.
26. Gerlach JC, Encke J, Hole O, Muller C, Ryan CJ, Neuhaus P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 1994; 58:984-8.
27. Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Muller AR, Steinmuller T, Denner J, Neuhaus P, Gerlach JC. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 2003; 10:460-9.
28. Irgang M, Sauer IM, Karlas A, Zeilinger K, Gerlach JC, Kurth R, Neuhaus P, Denner J. Porcine endogenous retroviruses: No infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol 2003; 28:141-54.
29. Sauer IM, Zeilinger K, Obermayer N, Pless G, Grunwald A, Pascher A, Mieder T, Roth S, Goetz M, Kardassis D, Mas A, Neuhaus P, Gerlach JC. Primary human liver cells as source for modular extracorporeal liver support-a preliminary report. Int J Artif Organs 2002;25:1001-5.
30. Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, Goetz M, Neuhaus P, Gerlach JC. Extracorporeal liver support based on primary human liver cells and albumin dialysis-treatment of a patient with primary graft nonfunction. J Hepatol 2003; 39:649-53.
31. Flendrig LM, Calise F, Di Florio E, Mancini A, Ceriello A, Santaniello W, Mezza E, Sicoli F, Belleza G, Bracco A, Cozzolino S, Scala D, Mazzone M, Fattore M, Gonzales E, Chamuleau RA. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 1999; 22:701-9.
32. Sosef MN, Abrahamse LS, van de Kerkhove MP, Hartman R, Chamuleau RA, van Gulik TM. Assessment of the AMC-bioartificial liver in the anhepatic pig. Transplantation 2002; 73:204-9.
33. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, Dauri M, Tisone G, Di Nicuolo G, Amoroso P, Spadari A, Lombardi G, Hoekstra R, Calise F, Chamuleau RA. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 2002; 25:950-9.
34. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, Scala D, Scala S, Zeuli L, Di Nicuolo G, Amoroso P, Calise F, Chamuleau RA. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. Cell Transplant 2003; 12:563-8.
35. Poyck PP, Pless G, Hoekstra R, Roth S, van Wijk AC, Schwartlander R, van Gulik TM, Sauer IM, Chamuleau RA. In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL. Int J Artif Organs 2007, (accepted).
36. Gislason GT, Lobdell DD, Kelly JH, Sussman NL. A treatment system for implementing an extracorporeal liver assist device. Artif Organs 1994; 18:385-9.
37. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: Initial clinical experience. Artif Organs 1994; 18:390-6.
38. Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24:1446-51.
39. Millis JM, Cronin DC, Johnson R, Conjeevaram H, Conlin C, Trevino S, Maguire P. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: System modifications and clinical impact. Transplantation 2002; 74:1735-46.
40. Demetriou AA, Rozga J, Podesta L, Lepage E, Morsiani E, Moscioni AD, Hoffman A, McGrath M, Kong L, Rosen H, et al. Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol Suppl 1995; 208:111-7.
41. Rozga J, Podesta L, LePage E, Hoffman A, Morsiani E, Sher L, Woolf GM, Makowka L, Demetriou AA. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342:898-9.
42. Rozga J, Podesta L, LePage E, Morsiani E, Moscioni AD, Hoffman A, Sher L, Villamil F, Woolf G, McGrath M, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994; 219:538-44, (discussion 544-6).
43. Hui T, Rozga J, Demetriou AA. Bioartificial liver support. J Hepatobiliary Pancreat Surg 2001; 8:1-15.
44. Mullon C, Pitkin Z. The HepatAssist bioartificial liver support system: Clinical study and pig hepatocyte process. Expert Opin Investig Drugs 1999; 8:229-35.
45. Demetriou AA, Brown Jr RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch IInd JS, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239:660-7, (discussion 667-70).
46. Iwata H, Ueda Y. Pharmacokinetic considerations in development of a bioartificial liver. Clin Pharmacokinet 2004; 43:211-25.
47. Sakamoto S, Uemoto S, Uryuhara K, Kim I, Kiuchi T, Egawa H, Inomata Y, Tanaka K. Graft size assessment and analysis of donors for living donor liver transplantation using right lobe. Transplantation 2001; 71:1407-13.
48. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev 2004, (CD003628).
49. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic review. Jama 2003; 289:217-22.